中順潔柔(002511.SZ):就新型冠狀病毒肺炎疫情 共捐贈1080萬元現金並提供50萬元衞生消毒濕巾和其他生活用紙
格隆匯2月2日丨中順潔柔(002511.SZ)公佈,面對全國多地區發生新型冠狀病毒肺炎疫情,公司作為生活用紙領域的第一梯隊企業,積極履行社會責任,共計捐贈1080萬元現金並提供50萬元衞生消毒濕巾和其他生活用紙。
其中,公司向湖北省慈善總會捐贈1000萬元現金、向孝感市孝南區慈善會捐贈50萬元現金,用於新型冠狀肺炎疫情防控專項專用,幫助湖北省抗擊疫情;並提供50萬元衞生消毒濕巾和其他生活用紙供醫護以及救援人員使用。
公司之全資子公司中順潔柔(雲浮)紙業有限公司向羅定市紅十字會捐贈30萬現金,用於羅定市新型冠狀病毒感染的肺炎疫情防控工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.